Jazz Pharmaceuticals plc 2015 Executive Officer Compensation Arrangements

Summary

This document outlines the 2015 compensation arrangements for executive officers of Jazz Pharmaceuticals plc. It lists the base salary rates and target bonus percentages for each executive, including the CEO, CFO, and other senior officers. The base salaries are generally effective as of March 1, 2015, with a specific start date for Dr. Karen Smith. Target bonuses are set as a percentage of annual base salary, determined by each officer's role and responsibilities under the company's cash bonus plans.

EX-10.3 3 jazzq12015ex103.htm JAZZ PHARMACEUTICALS PLC 2015 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS JAZZ Q1 2015 EX 10.3

Exhibit 10.3

2015 Executive Officer Compensation Arrangements



Executive Officer	Base Salary Rate⁽¹⁾	Target Bonus as % of Annual Base Salary Rate⁽²⁾

Bruce C. Cozadd Chairman and Chief Executive Officer	$875,000	100

Russell J. Cox Executive Vice President and Chief Operating Officer	$550,000	55

Suzanne Sawochka Hooper Executive Vice President and General Counsel	$500,000	55

Matthew P. Young Executive Vice President and Chief Financial Officer	$475,000	55

Iain McGill Senior Vice President, Jazz Pharmaceuticals Europe and Rest of World	£240,000	45

Michael P. Miller Senior Vice President, U.S. Commercial	$430,000	45

Karen Smith, M.D., Ph.D. Global Head of Research & Development and Chief Medical Officer	$475,000	45

Paul Treacy Senior Vice President, Technical Operations	€250,800	45

Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer	$310,000	45


(1)	2015 Base salary rates generally effective by March 1, 2015. Dr. Smith’s base salary rate is effective beginning on April 13, 2015, the commencement date of her employment.


(2)	Target bonus percentage for each officer is based on his or her position and/or responsibility level as provided in Jazz Pharmaceuticals plc’s cash bonus plans.